Background Treatment outcomes for multidrug-resistant tuberculosis remain poor. We aimed
to estimate the association of treatment success and death with the use of individual drugs …

Background The results of some reports have suggested that treatment of isoniazid-resistant
tuberculosis with the recommended regimens of first-line drugs might be suboptimal. We …

Drug-resistant tuberculosis is a substantial health-care concern worldwide. Despite culture-
based methods being considered the gold standard for drug susceptibility testing, molecular …

The emergence of drug-resistant strains of Mycobacterium tuberculosis is a challenge to
global tuberculosis (TB) control. Although culture-based methods have been regarded as …

We sought to compare the effectiveness of two World Health Organization (WHO)-
recommended regimens for the treatment of rifampin-or multidrug-resistant (RR/MDR) …

Background Isoniazid-resistant, rifampicin-susceptible (INH-R) tuberculosis is the most
common form of drug resistance, and is associated with failure, relapse, and acquired …

Background Current anti-tuberculosis therapeutics are not sufficiently effective against drug-
resistant tuberculosis (DR-TB), and there is a need for new drugs and therapeutic …

Multidrug-resistant (MDR) Mycobacterium tuberculosis complex (MTBC) strains represent a
major threat for tuberculosis (TB) control. Treatment of MDR-TB patients is long and less …

Rates and risk factors for acquired drug resistance and association with outcomes among
patients with multidrug-resistant tuberculosis (MDR TB) are not well defined. In an MDR TB …

summary The Soviet health care infrastructure and its tuberculosis-control system were
anchored in biomedicine, but the dire resurgence of tuberculosis at the end of the twentieth …